Please provide your email address to receive an email when new articles are posted on . Dupilumab was able to improve lichenification among patients aged 6 to 88 years with atopic dermatitis. Patients ...
Please provide your email address to receive an email when new articles are posted on . There may be value to adapt the original major and minor criteria to account for diverse patient populations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results